Bausch & Lomb LUMIFY receives FDA approval for eye redness December 29, 2017 Source: Sina medicine Author: Kerr Clinical studies have shown that 0.025% brimonidine tartrate eye drops achieve 95% symptom improvement in one minute and redness in 8 hours Bausch & Lomb, the world's leading eye care company, today announced that the US Food and Drug Administration (FDA) has approved LUMIFYTM (0.025% brimonidine tartrate eye drops) as a low-dose brimonidine tartrate. The first and only over-the-counter (OTC) eye drop is used to treat eye redness. Brimonidine was first approved by the FDA in 1996 to reduce intraocular pressure (IOP) in glaucoma patients, with higher doses in prescription ophthalmic care products. Bausch & Lomb is a wholly-owned subsidiary of Valeant, and Joseph C. Papa, Chairman and CEO of Valeant, said: “Today LUMIFY is certified, consumers have a new treatment to relieve eye redness. LUMIFY is the first and The only OTC eye drop using low-dose brimonidine. Brimonidine has been clinically proven safe and effective since it was first approved as a prescription drug in 1996. We expect LUMIY to be available in the second quarter of 2018. †Redness and swelling of the eyes are common symptoms that can be caused by almost any inflammation of the eyes. Clinically used non-selective redness-relieving eye drops can shrink blood vessels in the eye, causing resistance, loss of efficacy, and even redness and swelling. In contrast, low-dose brimonidine (the active ingredient in LUMIFY) selectively shrinks the intraocular veins, increasing the oxygen supply to surrounding tissues, thereby reducing the potential risk of these side effects. Dr. Paul Karpecki, MD, director of corneal services at the Kentucky Eye Institute, said: "Patients with red eyes and irritation may experience negative emotions that affect daily life. Reduced redness without side effects of recurrent hyperemia or rapid response, may also Lead to overuse and potential corneal toxicity, but it is still a very exciting option." The 0.025% product of brimonidine tartrate eye drops was originally developed by Eye Therapies, Inc. and then licensed to Bausch & Lomb. Article reference source: Bausch & Lomb Receives FDA Approval of LUMIFY Organic Rhodiola Rosea Extract
Organic Rhodiola Rosea extract is an extract from the root of Rhodiola Rosea. Organic Rhodiola Rosea Extract is a herb extract. It has a sweet smell and a bitter taste. The main ingredients are salidroside, aglycone tyrosol, and rosavin, which have the effects of enhancing immune function, protecting cardiovascular and cerebrovascular, anti-cancer, and anti-depressive effects.
As a professional manufacturer and supplier of Organic Rhodiola Rosea extract, our Rhodiola Rosea extract is produced, processed, and stored in strict accordance with EU and USDA organic standards. Our Organic Rhodiola Rosea extract is 100% traceable.
Our Rhodiola Rosea extracts are all extracted from wild-collected Rhodiola roots. Afterward, it is processed and stored in an organic environment. All these processes are fully traceable and verifiable.
Rhodiola Rosea Extract,Organic Rhodiola Rosea Extract,Rhodiola Rosea,Organic Rhodiola Rosea Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com